Systemic infusion of these CAR T cells into immunodeficient mice inhibited the growth of intracranial glioma xenografts in vivo, pointing to podoplanin as a potential target to treat glioblastomas by adoptive immunotherapy. The gene discussed is PDPN; the disease is glioma.